TABLE 1.

Demographic and clinical data of the patients under subcutaneous immunotherapy. In the rows from Age to Cost/Family income, values indicate the number of patients (percentage, if available). Other rows represent the median and IQR. p-values are omitted due to their large values.

Variables		Patients
		total	adherent	non-adherent
age	$\le 12$	96 (46.7)	40	56
	13–17	30 (14.6)	10	20
	$\ge 18$	79 (38.7)	23	56
gender	Female	62 (30.2)	22	40
	Male	143 (69.8)	51	92
distance to clinic (km)	$\le 10$	136 (66.3)	56	80
	$>10$	69 (33.7)	17	52
cost/family income (%)	$<30$	107 (52.4)	37	70
	30–50	77 (37.4)	32	45
	$>50$	21 (10.2)	4	17
EOS( $\times$ ${10}^9$ /L)		0.37; 0.41	0.36; 0.52	0.38; 0.36
EOS %		0.05; 0.04	0.05; 0.05	0.05; 0.05
$\mathrm{\Delta }$ NR (%)		16.67; 59.70	30.00; 92.80	14.80; 50.00
$\mathrm{\Delta }$ PNIF(%)		11.90; 34.50	12.70; 39.30	11.10; 28.80
total IgE (kU/L)		286; 543	340; 487	226; 555
sIgE of Der p (kU/L)		30.80; 68.480	31.30; 74.40	30.40; 67.80
sIgE of Der f (kU/L)		40.00; 68.20	40.60; 75.10	37.10; 65.70
Der p SPT SI		1.04; 0.58	1.00; 0.59	0.82; 0.55
Der f SPT SI		1.00; 0.50	0.82; 0.51	0.80; 0.45